The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms.
about
The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The anti-SLAMF7 antibody elotu ...... t and -independent mechanisms.
@en
The anti-SLAMF7 antibody elotu ...... t and -independent mechanisms.
@nl
type
label
The anti-SLAMF7 antibody elotu ...... t and -independent mechanisms.
@en
The anti-SLAMF7 antibody elotu ...... t and -independent mechanisms.
@nl
prefLabel
The anti-SLAMF7 antibody elotu ...... t and -independent mechanisms.
@en
The anti-SLAMF7 antibody elotu ...... t and -independent mechanisms.
@nl
P2093
P2860
P1433
P1476
The anti-SLAMF7 antibody elotu ...... nt and -independent mechanisms
@en
P2093
Alexander W MacFarlane
Ashley M James
Christine Bee
Karla A Henning
Kerry S Campbell
Michael D Robbins
Natalie A Bezman
Robert F Graziano
Tatiana Pazina
P2860
P304
P356
10.1080/2162402X.2017.1339853
P50
P577
2017-06-16T00:00:00Z